The Molecular Mechanisms of PCSK9-induced LDLR Degradation

Awardee: Chutikarn Butkinaree

Institution: Clinical Research Institute of Montreal

Award Amount: $35,000

Funding Period: January 1, 2015 - December 31, 2015

Previous
Previous

Reversal of epigenetic promoter silencing in Friedreich ataxia by histone deacetylase inhibitors

Next
Next

Dual targeting of defective lipid and metal pathways in Niemann-Pick type C disease: an in vitro pilot study